Seattle biotech company PhaseRX is being bought by multinational drug commercialization company Roivant Sciences, according to an SEC filing. Roivant… Read More
There weren’t many Seattle-area technology companies that completed IPOs in 2016, but it was enough to beat last year’s unprecedented drought.… Read More
Seattle-based biotech company PhaseRx develops drug candidates to treat rare, often life-threatening liver diseases, and one of their candidates just got… Read More
Plenty of companies promise to change people’s lives by offering them something that was perhaps previously unavailable. As the founder, president and… Read More
Wistar Kay, business development manager for the Washington State Department of Commerce, has announced her retirement effective Aug. 19, and… Read More
